Match tier
Listed
Presence
Current · Arkansas
Last published
2025
Sources
OpenAlex · ORCID
Refreshed
2026-10-09
Eric C. Peterson
High Impact
Professor
Also affiliated: Dartmouth College (2021); University of Minnesota (1981); The Royal Melbourne Hospital (2018); Johns Hopkins University (2018); University of Miami (2011–2024); The University of Melbourne (2018); University of California, Irvine (1994–1999); Durham Technical Community College (2016); Johns Hopkins Medicine (2018); Harborview Medical Center (2014); Boca Raton Regional Hospital (2018–2019); Jackson Memorial Hospital (2014–2023); Henry Ford Hospital (2008); Peterson (Norway) (2018–2024); Zimmer Biomet (United States) (1998); University of Miami Hospital (2015–2017); Duke Medical Center (1998–2004); University of Pittsburgh Medical Center (2017–2018); Miami Children's Hospital (2016); Health and Education Research Management and Epidemiologic Services (United States) (2023); Duke University Hospital (1998); Neurological Surgery (2009–2023); AdventHealth (2017); Toronto Metropolitan University (2021); Columbia University (2016); Tokushima University (2021)
Pharmacology & Toxicology, College of Medicine
38 h-index
153 pubs
5,380 cited
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Eric C. Peterson's research program focuses on the investigation of acute ischemic stroke, particularly the outcomes associated with endovascular thrombectomy. He has published extensively on this topic, examining factors such as interhospital transfer delays, the role of penumbral imaging, and the impact of general anesthesia on functional outcomes. His work includes meta-analyses of individual patient-level data to synthesize evidence from multiple studies.
Peterson also contributes to the understanding of cerebral aneurysms, studying their biology and physics, including formation, growth, and rupture. His research portfolio extends to other areas, including myeloma relapse and the development of cancer-related entrepreneurial technologies, for which he serves as Co-PI on a grant from the NIH/National Cancer Institute. His scholarship metrics include an h-index of 38, over 153 publications, and more than 5,380 citations, reflecting his designation as a highly cited researcher. He leads a research group and collaborates with several colleagues at the University of Arkansas for Medical Sciences.
Metrics
- h-index: 38
- Publications: 153
- Citations: 5,380
Positions
-
Professor publications 2014–2025University of Arkansas for Medical Sciences Pharmacology & Toxicology, College of Medicine Institutional directory
-
University of Miami Health SystemNeurological Surgery ORCID
Selected Publications
-
Case 3: An Uncommon Cause of Respiratory Distress in a Term Newborn (2025)
-
A functional surface display system in Saccharomyces boulardii for protein absorption in simulated intestinal fluids (2025)
-
Antagonizing the SAMD9 pathway is key to myxoma virus host shut-off and immune evasion (2024)
-
Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats (2023)
-
Liquid biopsy based on circulating tumor DNA for lung cancer: A step toward prevention (2023)
-
An advanced molecular medicine case report of a rare human tumor using genomics, pathomics, and radiomics (2023)
-
Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats (2022)
-
Effect of Antigen Retrieval on Genomic DNA From Immunodissected Samples (2022)
-
Myxoma virus lacking the host range determinant M062 stimulates cGAS-dependent type 1 interferon response and unique transcriptomic changes in human monocytes/macrophages (2022)
-
Abstract 5038: Applying reproducible genomic data science methods for the analysis of a rare tumor type (2022)
-
Methamphetamine‐Induced Proteomic Changes Within the Neuroinflammatory TLR4 Pathway Persist After Long‐Term Self‐Administration in Rats (2022)
-
Pharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations (2022)
-
Microdissection Methods Utilizing Single-Cell Subtype Analysis and the Impact on Precision Medicine (2022)
-
Myxoma virus lacking the host range determinant M062 stimulates cGAS-dependent type 1 interferon response and unique transcriptomic changes in human macrophages (2022)
-
NPARS—A Novel Approach to Address Accuracy and Reproducibility in Genomic Data Science (2021)
Federal Grants 1 $300,402 total
NIH
Co-PI
Sep 2025 - Aug 2030
Grants & Funding
As listed on this researcher's institutional profile. Federal awards with verified records are shown above.
- Active Immunization for Treating Methamphetamine Abuse NIH/Nat. Inst. on Drug Abuse Co-Investigator
- Pharmacology and Therapy for MDPV and alpha-PVP Like Drugs of Abuse NIH/Nat. Inst. on Drug Abuse Co-Investigator
- Antibody-based Therapy for Methamphetamine Abuse NIH/Nat. Inst. on Drug Abuse Co-Investigator
- Technology for Identification of Epiproteomes in Tissue Samples NIH Co-Investigator
- Single Chain Antibody Medications for(+)METH Abuse NIH Principal Investigator
- Antibody Gene Therapy for Methamphetamine Abuse NIH Principal Investigator
- Antibody-nanoparticle conjugates for the treatment of methamphetamine abuse NIH Principal Investigator
- Arkansas Collaborative for Technological and Innovative Venture Equality (ACTIVE) US Department of Commerce Principal Investigator
Collaboration Network
Top Collaborators
Donald J. Johann
Winthrop Rockefeller Foundation
23 shared publications
In database
- Liquid biopsy and its role in an advanced clinical trial for lung cancer
- Exogenous phosphatidic acid reduces acetaminophen-induced liver injury in mice by activating hepatic interleukin-6 signaling through inter-organ crosstalk
- Towards the integration, annotation and association of historical microarray experiments with RNA-seq
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- Enhancing cancer clonality analysis with integrative genomics
Showing 5 of 23 shared publications
Michael Bauer
University of Arkansas for Medical Sciences
13 shared publications
In database
- Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma
- Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker
- Towards the integration, annotation and association of historical microarray experiments with RNA-seq
- Enhancing cancer clonality analysis with integrative genomics
- Revealing the inherent heterogeneity of human malignancies by variant consensus strategies coupled with cancer clonal analysis
Showing 5 of 13 shared publications
Shweta S. Chavan
University of Arkansas for Medical Sciences (US)
11 shared publications
- Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma
- Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker
- Towards the integration, annotation and association of historical microarray experiments with RNA-seq
- Enhancing cancer clonality analysis with integrative genomics
- Revealing the inherent heterogeneity of human malignancies by variant consensus strategies coupled with cancer clonal analysis
Showing 5 of 11 shared publications
Christoph Heuck
University of Arkansas for Medical Sciences (US)
10 shared publications
- Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma
- Towards the integration, annotation and association of historical microarray experiments with RNA-seq
- Enhancing cancer clonality analysis with integrative genomics
- Revealing the inherent heterogeneity of human malignancies by variant consensus strategies coupled with cancer clonal analysis
- High Risk Multiple Myeloma Demonstrates Marked Spatial Genomic Heterogeneity Between Focal Lesions and Random Bone Marrow; Implications for Targeted Therapy and Treatment Resistance
Showing 5 of 10 shared publications
Owen Stephens
Winthrop Rockefeller Foundation (US)
10 shared publications
- Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma
- Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker
- Exogenous phosphatidic acid reduces acetaminophen-induced liver injury in mice by activating hepatic interleukin-6 signaling through inter-organ crosstalk
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- High Risk Multiple Myeloma Demonstrates Marked Spatial Genomic Heterogeneity Between Focal Lesions and Random Bone Marrow; Implications for Targeted Therapy and Treatment Resistance
Showing 5 of 10 shared publications
Peiyi Tang
University of Arkansas at Little Rock (US)
8 shared publications
- Mining probabilistic frequent closed itemsets in uncertain databases
- Fast approximation of probabilistic frequent closed itemsets
- Mining frequent sequential patterns with first-occurrence forests
- Mining probabilistic generalized frequent itemsets in uncertain databases
- A hybrid approach to mining frequent sequential patterns
Showing 5 of 8 shared publications
Matthew A. Steliga
Winthrop Rockefeller Foundation
8 shared publications
In database
- Liquid biopsy and its role in an advanced clinical trial for lung cancer
- An advanced molecular medicine case report of a rare human tumor using genomics, pathomics, and radiomics
- NPARS—A Novel Approach to Address Accuracy and Reproducibility in Genomic Data Science
- Effect of Antigen Retrieval on Genomic DNA From Immunodissected Samples
- Microdissection Methods Utilizing Single-Cell Subtype Analysis and the Impact on Precision Medicine
Showing 5 of 8 shared publications
Jason Muesse
Winthrop Rockefeller Foundation
8 shared publications
In database
- An advanced molecular medicine case report of a rare human tumor using genomics, pathomics, and radiomics
- NPARS—A Novel Approach to Address Accuracy and Reproducibility in Genomic Data Science
- Effect of Antigen Retrieval on Genomic DNA From Immunodissected Samples
- Microdissection Methods Utilizing Single-Cell Subtype Analysis and the Impact on Precision Medicine
- Synergizing microdissection with ddPCR to advance precision oncology.
Showing 5 of 8 shared publications
Niels Weinhold
University of Arkansas for Medical Sciences (US)
7 shared publications
- Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma
- Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker
- Enhancing cancer clonality analysis with integrative genomics
- High Risk Multiple Myeloma Demonstrates Marked Spatial Genomic Heterogeneity Between Focal Lesions and Random Bone Marrow; Implications for Targeted Therapy and Treatment Resistance
- The Impact of Combination Chemotherapy and Tandem Stem Cell Transplant on Clonal Substructure and Mutational Pattern at Relapse of MM
Showing 5 of 7 shared publications
Ik Jae Shin
Winthrop Rockefeller Foundation
7 shared publications
In database
- Liquid biopsy and its role in an advanced clinical trial for lung cancer
- An advanced molecular medicine case report of a rare human tumor using genomics, pathomics, and radiomics
- NPARS—A Novel Approach to Address Accuracy and Reproducibility in Genomic Data Science
- Effect of Antigen Retrieval on Genomic DNA From Immunodissected Samples
- Microdissection Methods Utilizing Single-Cell Subtype Analysis and the Impact on Precision Medicine
Showing 5 of 7 shared publications
Cody Ashby
University of Arkansas Medical Center
6 shared publications
In database
- Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma
- Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker
- Enhancing cancer clonality analysis with integrative genomics
- TarPan: an easily adaptable targeted sequencing panel viewer for research and clinical use
- High Risk Myeloma Is Characterized By the Bi-Allelic Inactivation of CDKN2C and RB1
Showing 5 of 6 shared publications
Gareth J. Morgan
University of Arkansas for Medical Sciences (US)
6 shared publications
- Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma
- Enhancing cancer clonality analysis with integrative genomics
- Spatiotemporal Analysis of Intraclonal Heterogeneity in Multiple Myeloma: Unravelling the Impact of Treatment and the Propagating Capacity of Subclones Using Whole Exome Sequencing
- High Risk Multiple Myeloma Demonstrates Marked Spatial Genomic Heterogeneity Between Focal Lesions and Random Bone Marrow; Implications for Targeted Therapy and Treatment Resistance
- The Impact of Combination Chemotherapy and Tandem Stem Cell Transplant on Clonal Substructure and Mutational Pattern at Relapse of MM
Showing 5 of 6 shared publications
Frits van Rhee
University of Arkansas for Medical Sciences
6 shared publications
In database
- Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma
- Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker
- High Risk Multiple Myeloma Demonstrates Marked Spatial Genomic Heterogeneity Between Focal Lesions and Random Bone Marrow; Implications for Targeted Therapy and Treatment Resistance
- The Impact of Combination Chemotherapy and Tandem Stem Cell Transplant on Clonal Substructure and Mutational Pattern at Relapse of MM
- Comprehensive Genomic Profiling of Multiple Myeloma in the Course of Clinical Care Identifies Targetable and Prognostically Significant Genomic Alterations
Showing 5 of 6 shared publications
Maurizio Zangari
University of Arkansas for Medical Sciences
6 shared publications
In database
- Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma
- Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker
- High Risk Multiple Myeloma Demonstrates Marked Spatial Genomic Heterogeneity Between Focal Lesions and Random Bone Marrow; Implications for Targeted Therapy and Treatment Resistance
- The Impact of Combination Chemotherapy and Tandem Stem Cell Transplant on Clonal Substructure and Mutational Pattern at Relapse of MM
- Comprehensive Genomic Profiling of Multiple Myeloma in the Course of Clinical Care Identifies Targetable and Prognostically Significant Genomic Alterations
Showing 5 of 6 shared publications
Faith E. Davies
University of Arkansas for Medical Sciences (US)
6 shared publications
- Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma
- Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker
- Spatiotemporal Analysis of Intraclonal Heterogeneity in Multiple Myeloma: Unravelling the Impact of Treatment and the Propagating Capacity of Subclones Using Whole Exome Sequencing
- High Risk Multiple Myeloma Demonstrates Marked Spatial Genomic Heterogeneity Between Focal Lesions and Random Bone Marrow; Implications for Targeted Therapy and Treatment Resistance
- The Impact of Combination Chemotherapy and Tandem Stem Cell Transplant on Clonal Substructure and Mutational Pattern at Relapse of MM
Showing 5 of 6 shared publications
Similar Researchers
Based on overlapping research topics
Hafiz Talha Javed
University of Arkansas for Medical Sciences
Acute Ischemic Stroke Management
Cerebrovascular and Carotid Artery Diseases
Meta-analysis and systematic reviews
Krishna Nalleballe
University of Arkansas for Medical Sciences
Acute Ischemic Stroke Management
Cerebrovascular and Carotid Artery Diseases
Medical Imaging Techniques and Applications
Sama Almasri
University of Arkansas for Medical Sciences
Acute Ischemic Stroke Management
Meta-analysis and systematic reviews
Medical Imaging Techniques and Applications
Soumya Unnikrishnan
University of Arkansas at Fayetteville
Meta-analysis and systematic reviews
Medical Imaging Techniques and Applications
Cancer Treatment and Pharmacology
Lindsay Blake
University of Arkansas for Medical Sciences
Meta-analysis and systematic reviews
Medical Imaging Techniques and Applications
Anesthesia and Pain Management
Sonya Utecht
University of Arkansas for Medical Sciences
Meta-analysis and systematic reviews
Medical Imaging Techniques and Applications
Cancer Treatment and Pharmacology